Temozolomide in Treating Patients With Invasive Pituitary Tumors

Clinical trial NCT00601289 · WITHDRAWN

Trial details

NCT number: NCT00601289
Sponsor: Jonsson Comprehensive Cancer Center
Status: WITHDRAWN
Phase: Phase 2
Study type: INTERVENTIONAL

Brain and Central Nervous System Tumors

Start date: 2009-12-01
Primary completion: 2010-10-01
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.